Exelixis
EXEL
#1664
Rank
C$18.33 B
Marketcap
C$72.96
Share price
-0.02%
Change (1 day)
22.54%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: C$76.03 CAD on 2026-06-11

Lowest end of day price: C$1.83 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 17.13%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
C$339.75 3.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$35.13-1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
C$493.13 0.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$59.12-0.43%๐Ÿ‡ซ๐Ÿ‡ท France
C$169.96 3.57%๐Ÿ‡บ๐Ÿ‡ธ USA
C$78.91 1.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$74.00 2.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.51-15.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.32 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA